Related Experiment Video
Updated: May 8, 2026

Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
No matrix effect in double-blind, placebo-controlled egg challenges in egg allergic children
L Libbers1, B M J Flokstra-de Blok, B J Vlieg-Boerstra
1Department of Paediatric Pulmonology and Paediatric Allergy, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
The fat content of food used in double-blind, placebo-controlled food challenges (DBPCFCs) did not significantly affect the dose needed to trigger a reaction or the reaction severity in children with hen's egg allergy. These findings differ from studies on peanut allergy.
Area of Science:
- Food allergy research
- Clinical immunology
- Pediatric allergy
Background:
- Food allergic reactions can be influenced by the food matrix.
- Previous studies with peanut allergy suggest fat content impacts reaction severity.
Purpose of the Study:
- To investigate if food matrix fat content affects eliciting dose and reaction severity in hen's egg allergy.
- Examine the role of different food matrices in double-blind, placebo-controlled food challenges (DBPCFCs).
Main Methods:
- Retrospective analysis of 59 children with egg allergy undergoing DBPCFCs.
- Used three recipes (pudding, pancake, minced meat) with varying fat content (22.8% to 52.7%).
- Analyzed eliciting dose and reaction severity using statistical models.
Main Results:
- No significant influence of recipe type (fat content) on eliciting dose was found (P=0.12).
- Reaction severity was not significantly different across the tested food matrices.
- Minced meat (highest fat) did not lead to significantly different outcomes compared to pudding or pancake.
Conclusions:
- Unlike peanut allergy research, hen's egg allergy DBPCFCs showed no significant effect of matrix fat content on eliciting dose or reaction severity.
- Matrix fat content may not be a universal co-determinant of reaction severity for all food allergens.
Related Concept Videos
Blind Procedures
Blinding
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions

